| J1566 | Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg | 3,890 | $60 | $237.3K |
| J0897 | Injection, denosumab, 1 mg | 12,960 | $20 | $233.3K |
| J1556 | Injection, immune globulin (bivigam), 500 mg | 2,550 | $60 | $142.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 710 | $130 | $90.2K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 2,890 | $20 | $63.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 520 | $90 | $45.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $100 | $40.4K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 19,590 | $1 | $39.2K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 610 | $60 | $37.5K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 1,050 | $20 | $22K |